Pharmaceutical formulations comprising 1-(beta-D-glucopyranosyl)-2-thienylmethylbenzene derivatives as inhibitors of SGLT

• 收藏
• 分享

专利权人:

Janssen Pharmaceutica NV

发明人:

Wang, Wenhua,Outwin, Todd,Joseph, Thomas C.

申请号：

AU2017210661

公开号：

AU2017210661A1

申请日:

2017.08.07

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

#$%^&*AU2017210661A120170824.pdf#####ABSTRACT The present invention relates to formulations including compounds of Formula (1), (Formula (1)) or prodrug, or a pharmaceutically acceptable salt thereof. [FIG 1]1/2 FIG. 1A CD a 100009000- o 5mg/mL Nanosuspenslon o 8000- u 4x25mg tablets E 7000. A 100mg tablet E 600031 00020000 1000CL 0 a)0 04 8 12 1620 24 28 32 36 40 44 48 Time (h) FIG. 1B E So100000 o 5mg/mL Nanosuspension o 4x25mg tablets C A 100mg tablet 10000a100 -n 0 100E S4 8 12 16 20 24 28 32 36 40 44 48 Time (h)

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/